HMMJ:CA:TSX-Global X Marijuana Life Sciences Index ETF (CAD)

ETF | Sector Equity |

Last Closing

CAD 11.04

Change

-0.24 (-2.13)%

Market Cap

CAD 0.09B

Volume

9.62K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.15 (+0.38%)

CAD 2.62B
ZWU:CA BMO Covered Call Utilities ETF

-0.04 (-0.39%)

CAD 1.82B
TXF:CA First Asset Tech Giants Covere..

+0.14 (+0.61%)

CAD 0.64B
XHC:CA iShares Global Healthcare (CAD..

-0.18 (-0.25%)

CAD 0.60B
XIT:CA iShares S&P/TSX Capped Informa..

+0.38 (+0.74%)

CAD 0.59B
HTA:CA Tech Achievers Growth & Income..

+0.15 (+0.80%)

CAD 0.58B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.12 (-0.59%)

CAD 0.44B
CWW:CA iShares Global Water Common Cl..

-0.16 (-0.28%)

CAD 0.34B
HHL:CA Harvest Healthcare Leaders Inc..

-0.02 (-0.18%)

CAD 0.33B
COW:CA iShares Global Agriculture Com..

-0.55 (-0.91%)

CAD 0.30B

ETFs Containing HMMJ:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.84% 100% F 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.84% 100% F 82% B
Trailing 12 Months  
Capital Gain 12.42% 53% F 60% D-
Dividend Return 1.94% 60% D- 34% F
Total Return 14.36% 53% F 60% D-
Trailing 5 Years  
Capital Gain -72.15% 6% D- 6% D-
Dividend Return 5.14% 38% F 21% F
Total Return -67.01% 6% D- 7% C-
Average Annual (5 Year Horizon)  
Capital Gain -9.44% 6% D- 7% C-
Dividend Return -7.06% 6% D- 8% B-
Total Return 2.38% 66% D+ 62% D
Risk Return Profile  
Volatility (Standard Deviation) 42.43% 9% A- 21% F
Risk Adjusted Return -16.63% 9% A- 24% F
Market Capitalization 0.09B 51% F 35% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.